|
#Welcome to
Acid Reflux/GERD and Heartburn - your comprehensive acid reflux resource.
Below, you'll find extensive information
on leading acid reflux articles and products to help you on your
way to success.
Acid Reflux Medicine - Find Treatment For A Personal Issue
Acid reflux is a very personal thing and your symptoms will determine the best way to resolve this condition for you. First, before treating a condition as acid reflux, it is important to determine if your symptoms are truly caused by or some other condition. More serious conditions can masquerade as when, in fact, they might require more serious treatment and even indicate a need for the care of a physician. However, if is the culprit, treatment mainly consists of changing lifestyle issues that trigger symptoms coupled with medicine such as antacid medications to help relieve the symptoms for you.
The key medical treatment for is to merely change your dietary lifestyle. The foods you eat serve to either heal or harm your system. Simply changing what you eat is the primary medical recommendation for anyone diagnosed with before medicine is prescribed.
For some individuals, though, a simple dietary lifestyle change may not be sufficient to alleviate the symptoms. The second line of defense used to treat is antacids. These medicines are effective against because they reduce the amount of acid present in the stomach. Foods that generate within your digestive system do so by causing harmful chemical reactions within your digestive system resulting in what is known as acid reflux. If there is less acid present, there is naturally a lesser occurrence of acid reflux.
Unfortunately, this naturally-occurring acid is necessary for normal digestion and using medicine like antacids to remove excess acid harms the digestive
Metformin Shows Anticancer Potential (CME/CE)
(MedPage Today) -- Nondiabetic patients with precancerous rectal lesions had significant histologic improvement after one month of treatment with metformin, data from a small randomized clinical trial showed.
Bisphosphonates Tied to Esophageal Cancer (CME/CE)
(MedPage Today) -- A second look at British registry data indicates that esophageal cancer may be more common after all in patients taking oral bisphosphonate drugs for long periods.
Cirrhosis Outcomes Better When Tx Guidelines Followed (CME/CE)
(MedPage Today) -- Routinely screening liver cirrhosis patients for esophageal varices and treating them according to published guidelines led to lower-than-expected rates of subsequent variceal hemorrhage, researchers found.
Death Risk Widens for Blacks With Colorectal Cancer (CME/CE)
(MedPage Today) -- The risk of death from colorectal cancer is greater for blacks than whites, and the differences have been widening for four decades, researchers said.
Hepatitis E Vaccine Candidate Completely Blocked Disease (CME/CE)
(MedPage Today) -- An investigational vaccine against hepatitis E was shown to be completely effective in a large randomized trial in China, researchers said.
CT Colonography Boosts High-Risk Yield (CME/CE)
(MedPage Today) -- CT colonography identified almost 80% more high-risk lesions compared with optical screening by adding extracolonic findings, a review of more than 2,000 cases showed.
Alcohol Use Before Liver Tx Key to Use Afterward (CME/CE, with audio)
(MedPage Today) -- Problem drinking after liver transplantation for alcoholic liver disease can be predicted by looking at just a few factors, a prospective study showed.
HBV Damage Disappears With Long-Term Therapy (CME/CE)
(MedPage Today) -- Long-term treatment with entecavir (Baraclude) at least partially reverses cirrhosis and fibrosis in most chronic hepatitis B patients, according to extended follow-up of a clinical trial.
No Benefit for Steroids in Allograft Renal Transplant (CME/CE)
(MedPage Today) -- Pretreatment of deceased donor kidneys with steroids failed to reduce the incidence of acute renal failure -- also known as delayed graft function -- in a randomized study conducted in central Europe.
Novel HCV Drug Can Double Response Rate (CME/CE)
(MedPage Today) -- An investigational protease inhibitor aimed at blocking hepatitis C replication can double the response rate compared with standard care, researchers said.
Chronic HBV Raises Lymphoma Risk (CME/CE)
(MedPage Today) -- Chronic hepatitis B virus infection -- common throughout Asia and Africa and often present since early in life -- raises the risk for non-Hodgkin's lymphoma, a large South Korean study confirmed.
African, European Kids Have Different Gut Bugs (CME/CE)
(MedPage Today) -- Children on a Western-style diet appear have different gut bacteria compared with African children, whose eating habits and living environment more closely resemble those of earlier ancestors, researchers have found.
Ablate and Wait in Liver CA, Experts Suggest (CME/CE)
(MedPage Today) -- Outcomes in all patients with hepatocellular carcinoma might improve with an "ablate-and-wait" strategy versus rapid transplantation, according to a group of clinicians who have regularly used the strategy.
Virtual Colonoscopy Misses Mark on Cost (CME/CE)
(MedPage Today) -- Virtual colonoscopy is cost-effective only when priced lower than conventional colonoscopy or if it attracts a large unscreened population, according to computer models of colon cancer screening strategies.
Gene Therapy Benefits Persist in SCID (CME/CE)
(MedPage Today) -- Gene therapy appears to have long-term success for treating X-linked severe combined immunodeficiency disease (SCID) -- but recipients are at risk for acute leukemia, according to a small study from France.
|
|
We strive to provide only quality articles, so
if there is a specific topic related to acid reflux that
you would like us to cover, please contact us at any time.
And again, thank you to those contributing daily
to our acid reflux website.
|
